GRADEpro

GRADEpro
Name	GRADEpro
Developer	GRADE Working Group
Released	2000s
Latest release version	proprietary web-based iterations
Programming language	web technologies
Operating system	Cross-platform (web)
Genre	Evidence synthesis, guideline development
License	Proprietary / subscription-based options

GRADEpro

GRADEpro is a software tool designed to support evidence assessment and guideline development using the GRADE approach. It provides structured interfaces for creating evidence profiles, Summary of Findings tables, and for managing recommendations in clinical practice guidelines. The tool is used by guideline developers, systematic reviewers, health technology assessment agencies, and professional societies.

Overview

GRADEpro implements the GRADE framework to help users assess certainty of evidence and translate evidence into recommendations. Prominent organizations and institutions that have employed the software include World Health Organization, Cochrane Collaboration, National Institute for Health and Care Excellence, U.S. Preventive Services Task Force, and assorted national ministries of health. The platform connects to networks of contributors from entities such as Canadian Agency for Drugs and Technologies in Health, European Medicines Agency, Centers for Disease Control and Prevention, and specialist societies like American College of Physicians and Royal College of Physicians. It interoperates with bibliographic and review infrastructure developed by groups including PubMed, Embase, PROSPERO, Cochrane Library, and guideline repositories such as Guidelines International Network.

History and Development

Development arose from methodological work by the GRADE Working Group, which included contributors affiliated with universities and institutions such as McMaster University, University of Oxford, Johns Hopkins University, McGill University, and University of Toronto. Early iterations paralleled advances in systematic review methodology published in journals like The BMJ, The Lancet, and JAMA. Collaborations extended to evidence synthesis programs at Agency for Healthcare Research and Quality and initiatives supported by foundations such as the Bill & Melinda Gates Foundation for global health guideline projects. Over time, the project evolved from standalone desktop utilities into web-hosted platforms incorporating input from guideline-producing bodies including American Medical Association and World Bank health programs.

Features and Functionality

Key functionalities include structured evidence tables, Summary of Findings generation, GRADE domains mapping, and recommendation panel support. Users can import data produced within review environments tied to databases like ClinicalTrials.gov and systematic review tools from groups such as Covidence and RevMan. The interface supports linkage to risk-of-bias instruments developed by panels including Cochrane Risk of Bias Tool authors and to outcome measures informed by classification systems like ICD-10. Reporting outputs are often incorporated into guideline documents submitted to publishers such as Elsevier and Wiley-Blackwell or presented at conferences organized by entities like World Health Assembly and European Respiratory Society. Collaborative features allow multidisciplinary teams including clinicians from Mayo Clinic, Johns Hopkins Hospital, and Massachusetts General Hospital to work with methodologists from institutions such as Institute for Clinical Evaluative Sciences.

Use in Guideline and Systematic Review Development

Guideline panels and systematic review teams use the software to synthesize evidence from randomized trials and observational studies, applying procedures recommended by groups such as GRADE Working Group and trial registries like ISRCTN. It facilitates transparent documentation of judgments about inconsistency, imprecision, indirectness, risk of bias, and publication bias cited in reports by bodies like NICE, WHO, and USPSTF. Outputs are used in guideline dissemination through channels including UpToDate, BMJ Best Practice, and specialty society guidelines by organizations such as American Heart Association and American College of Cardiology. Regulatory agencies including Food and Drug Administration and European Commission have indirectly benefited from standardized evidence summaries produced using the tool in health technology assessments.

Licensing, Accessibility, and Integration

The software is distributed under a model combining free academic access for some users and subscription or institutional licensing for enhanced cloud services. Integration options have been developed to connect with systematic review management platforms like Covidence and bibliographic services such as EndNote and Zotero. Training and dissemination have been supported by workshops at meetings hosted by Cochrane Collaboration, GRADE Working Group sessions at World Congress of Epidemiology, and method training programs at universities including McMaster University and Karolinska Institutet. Partnerships with organizations such as Evidence Aid and Global Health Network have promoted use in low- and middle-income country guideline projects.

Criticisms and Limitations

Critiques from methodologists and guideline developers have focused on usability, the steep learning curve noted by panels from institutions like Royal College of General Practitioners, and the need for better integration with complex data workflows used by teams at Cochrane and academic centers. Concerns have been raised about proprietary licensing barriers affecting uptake in resource-limited settings, noted by commentators associated with Médecins Sans Frontières and public health programs at World Health Organization. Others have highlighted limits in automated grading for novel evidence types encountered in contexts managed by agencies such as European Centre for Disease Prevention and Control and the need for customizable templates for specialty societies like American Society of Clinical Oncology and European Society of Cardiology.

Category:Clinical decision support software